GSK-200977

Study Sponsor: GSK

Study Title

Study 200977: Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

200977

Trial Registry Identification Number(#'s)

NCT02229227 2014-001821-34

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200977

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02229227

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2014-001821-34

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. This study is available in CDISC format.

Date Added to this Site

September 2020